Natixis Advisors, L.P. Sarepta Therapeutics, Inc. Transaction History

Natixis Advisors, L.P.

$51.3 Billion
Q3 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	BUY	$113.33 - $163.85 $1.38 Million - $1.99 Million	12,137 New	12,137 $1.92 Million
Q3 2023 Nov 13, 2023	BUY	$102.5 - $123.59 $16,400 - $19,774	160 Added 0.62%	26,026 $3.16 Million
Q2 2023 Aug 15, 2023	SELL	$106.4 - $157.19 $119,061 - $175,895	-1,119 Reduced 4.15%	25,866 $2.96 Million
Q1 2023 May 11, 2023	BUY	$117.53 - $155.99 $15,396 - $20,434	131 Added 0.49%	26,985 $3.72 Million
Q4 2022 Jan 27, 2023	BUY	$100.86 - $132.13 $51,035 - $66,857	506 Added 1.92%	26,854 $3.48 Million
Q3 2022 Nov 14, 2022	BUY	$75.71 - $119.24 $107,205 - $168,843	1,416 Added 5.68%	26,348 $2.91 Million
Q2 2022 Aug 12, 2022	SELL	$62.69 - $88.44 $139,046 - $196,159	-2,218 Reduced 8.17%	24,932 $1.87 Million
Q1 2022 May 12, 2022	BUY	$63.15 - $90.42 $104,576 - $149,735	1,656 Added 6.5%	27,150 $2.12 Million
Q4 2021 Feb 08, 2022	BUY	$77.28 - $99.42 $55,950 - $71,980	724 Added 2.92%	25,494 $2.3 Million
Q3 2021 Nov 15, 2021	BUY	$65.97 - $92.48 $41,824 - $58,632	634 Added 2.63%	24,770 $2.29 Million
Q2 2021 Aug 12, 2021	BUY	$69.38 - $86.75 $314,083 - $392,717	4,527 Added 23.09%	24,136 $1.88 Million
Q1 2021 May 05, 2021	SELL	$72.25 - $168.95 $60,112 - $140,566	-832 Reduced 4.07%	19,609 $1.46 Million
Q4 2020 Feb 12, 2021	BUY	$125.56 - $178.74 $1.03 Million - $1.47 Million	8,231 Added 67.41%	20,441 $3.49 Million
Q3 2020 Nov 12, 2020	BUY	$127.12 - $172.34 $58,602 - $79,448	461 Added 3.92%	12,210 $1.72 Million
Q2 2020 Aug 11, 2020	SELL	$93.0 - $171.7 $138,198 - $255,146	-1,486 Reduced 11.23%	11,749 $1.88 Million
Q1 2020 Apr 27, 2020	SELL	$82.38 - $131.64 $28,997 - $46,337	-352 Reduced 2.59%	13,235 $1.3 Million
Q4 2019 Feb 10, 2020	BUY	$76.53 - $135.58 $1.04 Million - $1.84 Million	13,587 New	13,587 $1.75 Million

Others Institutions Holding SRPT

# of Institutions

525

Shares Held

84.4M

Call Options Held

2.06M

Put Options Held

1.52M

Black Rock Inc. New York, NY

10.3M
Shares

$1.17 Billion
0.04% of portfolio
Vanguard Group Inc Valley Forge, PA

8.97M
Shares

$1.02 Billion
0.02% of portfolio
Capital International Investors Los Angeles, CA

6.26M
Shares

$712 Million
0.16% of portfolio
Janus Henderson Group PLC London, X0

4.36M
Shares

$496 Million
0.29% of portfolio
State Street Corp Boston, MA

4.27M
Shares

$486 Million
0.02% of portfolio

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $9.96B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.

Account